Page last updated: 2024-08-17

carbostyril and Kidney Diseases

carbostyril has been researched along with Kidney Diseases in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (52.63)18.2507
2000's4 (21.05)29.6817
2010's3 (15.79)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Huyan, T; Li, X; Liu, Q; Shi, Y; Su, J; Tie, L; Wang, D; Wang, Q; Wang, Y; Zhang, F; Zou, X1
Edelman, A; Gauthier, S; Guerrera, IC; Hinzpeter, A; Jung, V; Martignetti, L; Nguyen-Khoa, T; Pranke, I; Semeraro, M; Sermet-Gaudelus, I; Stoven, V1
Bullins, KW; Denham, JW; Hanley, AV; Hanley, GA; Harirforoosh, S; Panus, PC; Wood, RC; Wyatt, JE1
Akahoshi, Y; Fujiki, H; Ikeda, T; Iwanaga, Y; Miyazaki, S; Morooka, H; Watanabe, H1
Boulton, DW; Bramer, SL; Mallikaarjun, S; Shoaf, SE1
Boucek, P; Honsova, E; Lodererova, A; Slatinska, J1
Bramer, SL; Kitani, M; Miyamoto, G; Tammara, B; Trang, JM1
Chandraker, A; Josephson, MA; Randhawa, PS; Williams, JW1
Kinoshita, Y; Miki, A; Nagasaki, Y; Ohtani, H; Sata, H; Sawada, Y; Tsujimoto, M1
Ishibashi, Y; Nogita, T; Shimada, J1
Bramer, SL; Efthymiopoulos, C; Gambertoglio, JG; Maroli, A1
Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA1
Marstein, S; Nilsen, OG; Saltvedt, E; Walstad, RA1
Feistauer, SM; Georgopoulos, A; Georgopoulos, M; Graninger, W; Pfleger, S1
Coffey, AK; Dousa, TP; Homma, S; O'Sullivan, DJ; Valtin, H1
Pernet, AG1
Kinzig, M; Mahr, G; Muth, P; Naber, KG; Sorgel, F1
Braeckman, R; Craft, JC; Granneman, GR; Kraut, J; Shupien, S1
Blum, RA; Schentag, JJ; Schultz, RW1

Reviews

3 review(s) available for carbostyril and Kidney Diseases

ArticleYear
Polyomavirus-associated nephropathy: update on antiviral strategies.
    Transplant infectious disease : an official journal of the Transplantation Society, 2006, Volume: 8, Issue:2

    Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Organophosphonates; Polyomavirus; Polyomavirus Infections; Quinolones

2006
Clinical pharmacokinetics of sparfloxacin.
    Clinical pharmacokinetics, 1993, Volume: 25, Issue:5

    Topics: Aging; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Japan; Kidney Diseases; Quinolones

1993
Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    The American journal of medicine, 1991, Dec-30, Volume: 91, Issue:6A

    Topics: Aging; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Kidney Diseases; Liver Diseases; Quinolones; Tissue Distribution

1991

Trials

2 trial(s) available for carbostyril and Kidney Diseases

ArticleYear
Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole.
    Clinical pharmacokinetics, 2008, Volume: 47, Issue:8

    Topics: Adult; Aged; Antipsychotic Agents; Area Under Curve; Aripiprazole; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Piperazines; Protein Binding; Quinolones; Severity of Illness Index

2008
The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:12

    Topics: Adult; Aged; Cardiotonic Agents; Chromatography, High Pressure Liquid; Female; Heart Failure; Humans; Indicators and Reagents; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Middle Aged; Quinolones; Reproducibility of Results; Time Factors

2002

Other Studies

14 other study(ies) available for carbostyril and Kidney Diseases

ArticleYear
FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis.
    British journal of pharmacology, 2020, Volume: 177, Issue:2

    Topics: Animals; Apoptosis; Cell Line; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Forkhead Box Protein O1; Humans; Kidney Diseases; Kidney Tubules; Male; Mice, Inbred C57BL; Mitochondria; Mitophagy; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Quinolones; Reperfusion Injury; Signal Transduction

2020
Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease.
    International journal of molecular sciences, 2020, Sep-10, Volume: 21, Issue:18

    Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Drug Combinations; Exosomes; Humans; Indoles; Kidney Diseases; Proteome; Quinolones; Young Adult

2020
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
    European journal of pharmacology, 2013, Nov-15, Volume: 720, Issue:1-3

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cell Adhesion Molecules; Creatinine; Diclofenac; Dinoprostone; Drug Interactions; Kidney; Kidney Diseases; Male; Nitric Oxide; Potassium; Pyrazoles; Quinolones; Rats; Rats, Sprague-Dawley; Sodium; Sulfonamides

2013
Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Male; Piperidines; Quinolones; Rats, Inbred Dahl; Receptors, Vasopressin; Time Factors; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling

2015
Cured malakoplakia of the renal allograft followed by long-term good function: a case report.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2012, Volume: 156, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Female; Humans; Kidney Diseases; Kidney Transplantation; Malacoplakia; Pancreas Transplantation; Quinolones

2012
Dosage adjustment of quinolone antibiotics and angiotensin-converting enzyme inhibitors in patients with renal dysfunction.
    International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Creatinine; Humans; Kidney Diseases; Quinolones

2006
Effect of renal impairment on the pharmacokinetics of grepafloxacin.
    Clinical pharmacokinetics, 1997, Volume: 33 Suppl 1

    Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Creatinine; Female; Fluoroquinolones; Humans; Kidney Diseases; Male; Middle Aged; Piperazines; Quinolones

1997
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome

1998
Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    The American journal of medicine, 1992, Apr-06, Volume: 92, Issue:4A

    Topics: Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Creatinine; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Kidney; Kidney Diseases; Linear Models; Male; Middle Aged; Quinolones

1992
Antibacterial activity of sparfloxacin against experimental renal infections in mice.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2

    Topics: Abscess; Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Fluoroquinolones; Half-Life; Kidney Diseases; Methicillin Resistance; Mice; Quinolones; Staphylococcal Infections

1992
Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
    The American journal of physiology, 1991, Volume: 261, Issue:4 Pt 2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Membrane; Cyclic AMP; Diabetes Insipidus; Freeze Fracturing; Isoenzymes; Kidney Diseases; Mice; Mice, Mutant Strains; Microscopy, Electron; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinolones; Rolipram

1991
Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    The American journal of medicine, 1991, Dec-30, Volume: 91, Issue:6A

    Topics: Age Factors; Aged; Anti-Infective Agents; Bacterial Infections; Drug Interactions; Female; Fluoroquinolones; Humans; Kidney Diseases; Male; Quinolones; Risk Factors; Sex Factors

1991
Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:11

    Topics: Adult; Aged; Anti-Infective Agents; Fluoroquinolones; Half-Life; Humans; Kidney Diseases; Male; Middle Aged; Quinolones; Renal Dialysis; Tissue Distribution

1991
Pharmacokinetics of lomefloxacin in renally compromised patients.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:12

    Topics: 4-Quinolones; Anti-Infective Agents; Female; Fluoroquinolones; Glucuronates; Half-Life; Humans; Kidney Diseases; Male; Quinolones; Renal Dialysis

1990